BlumenkrantzM.J., GahlG.M., KoppleK.D.Protein losses during peritoneal dialysis.Kidney Int1981; 19: 593–602.
3.
NolphK.D., MooreH.L., TwardowskiZ.J., KhannaR., GamboaS., KeshaviahP.Chronic ambulatory peritoneal dialysis with a high flux membrane.ASAIO J1993; 39: 904–9.
4.
BlakeP.G., FlowerdewG., BlakeR.M., OreopoulosD.G.Serum albumin in patients on CAPD: Predictors and correlation with outcome.J Am Soc Nephrol1993; 3: 1501–7.
5.
BlakeP.G., SombolosK., IzattS.A highly permeable peritoneal membrane is an adverse risk factor in CAPD (Abstract).Clin Invest Med1991; 14: A127.
6.
ChurchillD.N., ThorpeK.E., NolphK.D., KeshaviahP.K., OreopoulosD.G., PageD.Increased peritoneal membrane transport is associated with decreased patient and technique survival for continuous peritoneal dialysis patients.J Am Soc Nephrol1998; 9: 1285–92.
LittleJ., PhillipsL., RussellL., GriffithsA., RussellG.I., DaviesS.J.Longitudinal lipid profile on CAPD: their relationship to weight gain, comorbidity and dialysis factors.J Am Soc Nephrol1998; 9: 1981–9.
11.
YoungG.A., KoppleJ.D., LindholmB.Nutritional assessment of CAPD patients: An international study.Am J Kidney Dis1991; 4: 462–71.
12.
MarcusR.G., ChaingE., DimaanoF., UribarriJ.Serum albumin: Associations and significance in peritoneal dialysis. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1994; 10: 94–8.
13.
NolphK.D., KhannaR., TwardowskiZ.J., MooreH.L.Predictors of serum albumin concentration in CAPD (Abstract).J Am Soc Nephrol1992; 3: 416.
14.
Díaz–AlvarengaA., Abasta–JimenezM., BravoB., GambaG., Correa–RotterR.Serum albumin and body surface area are the strongest predictors of the peritoneal transport type. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1994; 10: 47–51.
15.
HartyJ.C., BoultanH., VenningM.C., GokalR.Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patient.Miner Electrolyte Metab1996; 22: 97–101.
16.
PranayK., HaroldL.M., KhannaR., TwardowskiZ.J., SharadG., NolphK.D.Effects of dialysis modality and membrane characteristics on dialysate protein losses of patients on peritoneal dialysis.Perit Dial Int1997; 3: 449–54.
17.
LinJ.J., WadhwaN.K., SuhH., GabraldaT., PatlakC.S.Increased peritoneal solute transport in diabetic peritoneal dialysis. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1995; 11: 63–6.
18.
PrakashK.C., AnnigeriR.The PET: Comparison of high, high-average and low, low-average PET in Indian CAPD (Letter).Perit Dial Int1995; 15(8): 388–9.
19.
HazeldineD.C., WaldekS., WoodG.N.I.Changes in lipid profile including lipoprotein (a1), in relation to dialy-sate protein losses in CAPD patients.Perit Dial Int1997; 17(Suppl 1): S61.
20.
WuC.H., HuangC.C., HuangJ.Y., WuM.S., LeuM.L.High flux peritoneal membrane is a risk factor in survival of CAPD treatment. In: KhannaR., ed. Advances in peritoneal dialysis.Toronto: Peritoneal Dialysis Publications, 1996; 12: 105–9.